Skip to main content

Trial launched testing existing drugs in bid to treat coronavirus patients

Treating Covid-19 patients may change after a nationwide trial has launched at Addenbrooke's hospital in Cambridge.


Researchers are testing two existing drugs in a bid to stop what seems to be the body's immune system overreacting to the infection. The first drug called Baricitinib is used to treat arthritis which calms part of the body's immune response by blocking crucial messenger chemicals called Cytokines. The other drug, Ravulizumab, is commonly used to treat a rare blood disorder which targets proteins called Complement which often go rogue and can destroy healthy Covid patients.

The trial is selecting Covid-19 patients who are at risk of ending up at intensive care, where many suffer multiple suffer organ failure - not caused by the virus but by our body's response to it.

For more information visit: ITV  News

Published May 21, 2020

Latest from CCTU

New clues about irritable bowel syndrome found in the brain

Breakthrough research led by Addenbrooke's Hospital gives IBS patients like Laura Tebbs a better understanding of their condition.

Researchers eye up new gene therapy trial that could reverse hereditary blindness

Restoration of sight from a rare genetic mutation may now become a reality thanks to a prestigious award from the National Institute for Health Research (…

Artificial pancreas trialled for outpatients with type 2 diabetes for first time

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis.

All news